These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [A resected case of hilar cholangiocarcinoma treated with neoadjuvant chemoradiation therapy].
    Author: Yamada K, Sakamoto K, Tamesa T, Matsui H, Shindo Y, Tokumitsu Y, Hashimoto N, Iida M, Maeda Y, Tokuhisa Y, Suzuki N, Yoshimura K, Ueno T, Takahashi M, Shibuya K, Kondo T, Oka M.
    Journal: Gan To Kagaku Ryoho; 2013 Nov; 40(12):1756-8. PubMed ID: 24393912.
    Abstract:
    The patient was a 69-year-old woman with elevated levels of hepatobiliary enzymes. An abdominal computed tomography (CT) scan revealed an enhanced mass in the liver hilum with dilatation of the intrahepatic bile duct. We diagnosed hilar cholangiocarcinoma and administered neoadjuvant chemoradiation therapy because of the possibility of tumor cells remaining at the surgical margins. Radical surgery was performed and pathological examination showed the tumor to be Grade 2b according to the Oboshi-Shimosato classification. Although postoperative bile leakage and intra-abdominal abscess were observed, the patient was discharged on day 82 after surgery. The patient is still alive without recurrence at 17 months after the surgery. Neoadjuvant chemoradiation therapy has the potential to obtain a negative surgical margin in patients with hilar cholangiocarcinoma, which is likely to be positive for cancer cells at the surgical margin in preoperative diagnosis.
    [Abstract] [Full Text] [Related] [New Search]